Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Biopharmaceuticals Market by Product (Monoclonal Antibody, Interferon, Insulin, Growth and Coagulation Factor, Erythropoietin, Vaccine, Hormone, And Others) and by Application (Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology, And Others)- Global Opportunity Analysis and Industry Forecast 2022-2030
... Opportunity Analysis and Industry Forecast 2022-2030 The Biopharmaceuticals Market was valued at USD 345.84 billion in 2021 and is predicted to reach USD 974.48 billion by 2030 with a CAGR of 11.7% from 2022-2030. Biopharmaceutical ... Read More
-
Diabetes Pen - Market Insights, Competitive Landscape and Market Forecast-2026
... End User (Hospitals & Clinics, Homecare Settings, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancements in product development and increasing prevalence of diabetes. ... Read More
-
Diabetic Gastroparesis - Epidemiology Forecast-2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Diabetic Gastroparesis Understanding The DelveInsight Diabetic Gastroparesis ... Read More
-
Diabetic Macular Edema (DME) - Market Insight, Epidemiology and Market Forecast -2032
... (DME) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Diabetic Macular Edema (DME) market report provides current treatment practices, emerging drugs, Diabetic Macular Edema (DME) market ... Read More
-
Diabetic Macular Edema (DME) - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Diabetic Macular Edema ... Read More
-
Insulin Resistance - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Insulin Resistance Understanding The DelveInsight Insulin Resistance ... Read More
-
Smart Insulin Pens- Market Insights, Competitive Landscape and Market Forecast–2026
... forecasted Smart Insulin Pens market trends, globally, which comprises of North America, Europe, APAC, and RoW. The Smart Insulin Pens market report provides an overview of Smart Insulin Pens, applications of Smart Insulin Pens as ... Read More
-
Diabetes - Market Insight, Epidemiology and Market Forecast -2032
... Spain, Italy, France, and United Kingdom) and Japan. The Diabetes market report provides current treatment practices, emerging drugs, Diabetes market share of the individual therapies, current and forecasted Diabetes market Size from 2019 to 2032 ... Read More
-
Diabetic Neuropathy - Market Insight, Epidemiology and Market Forecast -2032
... States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Diabetic Neuropathy market report provides current treatment practices, emerging drugs, Diabetic Neuropathy market share of the individual therapies, current and forecasted Diabetic Neuropathy ... Read More
-
Diabetic Nephropathy - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Diabetic Nephropathy Understanding The DelveInsight Diabetic Nephropathy ... Read More
-
Type 2 Diabetes - Epidemiology Forecast - 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Type 2 Diabetes Understanding The ... Read More
-
Diabetic Foot Ulcers (DFUs) - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Diabetic Foot Ulcers ... Read More
-
Diabetic Foot - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Diabetic Foot Understanding The DelveInsight Diabetic Foot ... Read More
-
The Market for In Vitro Diagnostic Tests in Latin America
... (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela and other nations), focuses on the market for reagents and instruments in the most important countries of the continent. Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are ... Read More
-
Diabetic Retinopathy (DR)
... includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable targets • ... Read More
-
Outlook of Diabetic Macular Edema – Current Landscape and the Way Forward
... of diabetes amongst the developed nations. In 2018, ~2.4m people in the US had DME, of that only ~70% got diagnosed and treated. Following is the current treatment paradigm for DME - the first line ... Read More
-
Syndicated Quarterly Diabetes Market Share Tracker Europe
... sizes and market share by brand with NPS score. Includes drivers and barriers, types of usage and patient preferences, brand attributes ranking, plus country-specific reimbursement landscape and changes, digital health/diabetes apps chapter. In it's fourth ... Read More
-
The Worldwide Market for Point-of-Care (POC) Diagnostics, 7th Edition (Infectious Disease Testing, POC Cancer Tests, Rapid Coagulation, Urine Testing, Lipid Tests, Pregnancy Testing, Glucose Testing and Other POC)
... a fast-growing and competitive category of the in vitro diagnostic market. Point-of-care (POC) tests are diagnostics performed outside the central laboratory or executed via decentralized testing. POC testing has skyrocketed in the last 20 years ... Read More
-
The World Market for HbA1c Tests
... being spent annually on HbA1c testing, for both professional and self-testing. Over a dozen companies produce analyzers, reagents, workstations, and point-of-care (POC) devices that run HbA1c tests. A major contributing factor to growth is the ... Read More
-
Global Type 1 Diabetes Market and Competitive Landscape – 2017
... market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Type 1 Diabetes market size and drug sales. This research also provides insights into Type 1 Diabetes epidemiology ... Read More
-
Pancreatic Beta-Cell Protection - Hot Targets & Pipeline Analysis
... protection in both Type-1 diabetes & Type-2 diabetes disease progression. This report enables Pharmaceutical /Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze ... Read More
-
Insulin Delivery Devices - Global Trends, Estimates and Forecasts, 2014-2021 Industry Overview
... all over the world and is projected to impact another 592 million by 2035. 29.1 million Americans that is 9.3% of the population have diabetes of both types and close to 2.5 million Americans presently ... Read More
-
Insulin Delivery Devices - Global Trends, Estimates and Forecasts, 2014-2021 Market Analysis
... databases, company websites, press releases & published research reports are also used for estimates. INSULIN DELIVERY DEVICES – GLOBAL Global market for Insulin Delivery Devices is projected to reach US$16.8 billion by 2021, recording a ... Read More
-
Insulin Delivery Devices - Global Trends, Estimates and Forecasts, 2014-2021 Report Focus
... disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research ... Read More
-
Global Diabetic Footwear Market Outlook 2021
... or lack of sensation in any part of his body, particularly in his feet. Diabetic/therapeutic shoes have evolved as a medical revolution as it aids in preventing the feet of a diabetic person from developing ... Read More
Research Assistance
